{'fraction_non_alphanumeric': 0.02849002849002849, 'fraction_numerical': 0.017094017094017096, 'mean_word_length': 5.632075471698113, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A step-by-step approach to the treatment of cardiovascular risk factors in patients with established atherosclerotic cardiovascular disease: ESC guidelines (2021)

In 2021, the European Society of Cardiology (ESC) updated its guidelines for the prevention of cardiovascular disease in clinical practice. 
The article analyzes the changes outlined in the updated ESC guidelines (2021), in particular, a step-by-step approach to individualized treatment of cardiovascular risk factors in patients with established atherosclerotic cardiovascular disease. The latter can be most effectively implemented through a strategy of using a combination of drugs in one tablet – polyp (polypill) as a basic therapy.